New developments in the treatment of obstructive sleep apnoea

Simonds, Anita K.
August 2000
Thorax;Aug2000 Supplement 1, Vol. 55, pS45
Academic Journal
No abstract available.


Related Articles

  • Indometacin.  // Reactions Weekly;5/15/2010, Issue 1301, p29 

    The article describes the case of a man who developed exacerbation of obstructive sleep apnoea while receiving treatment with indometacin.

  • 2. Treatment of sleep apnoea syndrome.  // GP: General Practitioner;11/4/2002, p71 

    Focuses on treatment of obstructive sleep apnoea syndrome (OSAS). Widely used treatment of obstructive sleep apnoea syndrome; Effectiveness of sonoplasty for treatment of patients with sleep disorders; Causes of snoring besides OSAS.

  • Obstructive sleep apnoea.  // Nursing Standard;8/8/2007, Vol. 21 Issue 48, p58 

    A quiz concerning obstructive sleep apnoea is presented.

  • Time to wake up to the costs of sleep apnoea syndrome in NZ.  // PharmacoEconomics & Outcomes News;10/2/2010, Issue 613, p10 

    The article discusses research on the cost of treating obstructive sleep apnoea syndrome (OSAS) in New Zealand, which references the study "Societal Costs of Obstructive Sleep Apnoea Syndrome," by P. Gander et al.

  • Tongue exercise for sleep apnoea.  // GP: General Practitioner;5/15/2009, p14 

    The article reports on a study that examines the association of tongue and neck exercise and sleep apnoea. According to this Brazilian study, tongue and neck exercise can reduce symptoms of obstructive sleep apnoea. Researchers suggested that this exercise is a promising alternative for the...

  • Obstructive sleep apnoea: CPAP may be effective treatment for associated metabolic syndrome.  // Africa Health;Mar2012, Vol. 34 Issue 3, p56 

    The article focuses on the trial on the effects of the continuous positive airway pressure (CPAP) on the metabolic syndrome in patients with obstructive sleep apnoea in New Delhi, India, which shows that the treatment can lower blood pressure and improve the metabolic abnormalities.

  • Morphine/oxycodone/paracetamol.  // Reactions Weekly;5/7/2011, Issue 1350, p34 

    The article describes cases of two patients who developed obstructive sleep apnoea during chronic opioid therapy for pain syndromes.

  • Somatropin.  // Reactions Weekly;2/12/2011, Issue 1338, p31 

    The article describes the case of a girl who developed obstructive sleep apnoea (OSA) while receiving somatropin for Prader Willi syndrome.

  • The obstructive sleep apnoea/hypopnoea syndrome. Douglas, N.J. // Practical Neurology;Feb2003, Vol. 3 Issue 1, p22 

    Focuses on the neurological disorder termed as sleep apnoea/hypopnoea syndrome. Clinical features of the neurological disorder; Implications of obstructive sleep apnoea/hypopnoea syndrome; Diagnosis of the neurological disorder and treatment.

  • Clinical trials in obstructive sleep apnoea.  // Thorax;Dec2013 Supplement, Vol. 68 Issue S3, pA4 

    The article presents abstracts on clinical trials topics which include a controlled trial of devices for obstructive sleep apnoea-hypopnea, effect of positive airway pressure on sleep apnea patients' blood pressure, and perception of clinicians on treatment of obstructive sleep apnoea patients.


Read the Article


Sign out of this library

Other Topics